Scientists test new Drug's safety in healthy men
NCT ID NCT07166796
Summary
This was an early safety study to understand how the body processes a drug called Tolvaptan. It involved 64 healthy male volunteers who received either a single dose or multiple doses. The main goal was to measure how much of the drug gets into the blood, how long it stays, and how the body breaks it down.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.